Skip to content
10-Q/A

Quarterly Report

FIRST CHINA PHARMACEUTICAL GROUP, INC.

0001062993-12-003159

← back to feed
Filed
Aug 21, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 15, 2012 59.66M sh
Shares Diluted Q2 2012 · Jun 30, 2012 59.66M sh
Shares Diluted Q2 2012 · Jun 30, 2012 59.66M sh
Shares Diluted restated Q2 2012 · Jun 30, 2011 59.51M sh
Shares Diluted restated Q2 2012 · Jun 30, 2011 57.42M sh
Capex Q2 2012 · Jun 30, 2012 $29.04K
Capex Q2 2012 · Jun 30, 2011 $11.77K
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$1.75M
Operating Cash Flow restated Q2 2012 · Jun 30, 2011 $1.95M
Short Term Debt Q2 2012 · Jun 30, 2012 $2.62M
Short Term Debt Q2 2012 · Dec 31, 2011 $0
Cash And Equivalents Q2 2012 · Jun 30, 2012 $4.61M
Cash And Equivalents Q2 2012 · Dec 31, 2011 $3.64M
Cash And Equivalents restated Q2 2012 · Jun 30, 2011 $4.22M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $1.13M
Stockholders Equity Q2 2012 · Jun 30, 2012 −$3.02M
Stockholders Equity Q2 2012 · Dec 31, 2011 −$3.78M
Current Liabilities Q2 2012 · Jun 30, 2012 $20.98M
Current Liabilities Q2 2012 · Dec 31, 2011 $14.92M
Total Liabilities Q2 2012 · Jun 30, 2012 $23.4M
Total Liabilities Q2 2012 · Dec 31, 2011 $16.61M
Current Assets Q2 2012 · Jun 30, 2012 $19.82M
Current Assets Q2 2012 · Dec 31, 2011 $12.64M
Total Assets Q2 2012 · Jun 30, 2012 $20.37M
Total Assets Q2 2012 · Dec 31, 2011 $12.83M
Eps Diluted Q2 2012 · Jun 30, 2012 $0.04
Eps Diluted Q2 2012 · Jun 30, 2012 $0.01
Eps Diluted restated Q2 2012 · Jun 30, 2011 $0.03
Eps Diluted restated Q2 2012 · Jun 30, 2011 $0.02
Eps Basic Q2 2012 · Jun 30, 2012 $0.04
Eps Basic Q2 2012 · Jun 30, 2012 $0.01
Eps Basic restated Q2 2012 · Jun 30, 2011 $0.03
Eps Basic restated Q2 2012 · Jun 30, 2011 $0.02
Sga Expense Q2 2012 · Jun 30, 2012 $204.51K
Sga Expense Q2 2012 · Jun 30, 2012 $891.15K
Sga Expense Q2 2012 · Jun 30, 2011 $475.16K
Sga Expense Q2 2012 · Jun 30, 2011 $1M
Net Income Q2 2012 · Jun 30, 2012 $2.3M
Net Income Q2 2012 · Jun 30, 2012 $740.23K
Net Income restated Q2 2012 · Jun 30, 2011 $1.73M
Net Income restated Q2 2012 · Jun 30, 2011 $1.39M
Operating Income Q2 2012 · Jun 30, 2012 $1.16M
Operating Income Q2 2012 · Jun 30, 2012 $1.44M
Operating Income Q2 2012 · Jun 30, 2011 $815.94K
Operating Income restated Q2 2012 · Jun 30, 2011 $946.45K
Gross Profit Q2 2012 · Jun 30, 2012 $1.47M
Gross Profit Q2 2012 · Jun 30, 2012 $2.53M
Gross Profit Q2 2012 · Jun 30, 2011 $1.34M
Gross Profit restated Q2 2012 · Jun 30, 2011 $2.64M
Cost Of Revenue Q2 2012 · Jun 30, 2012 $12.57M
Cost Of Revenue Q2 2012 · Jun 30, 2012 $23.69M
Cost Of Revenue Q2 2012 · Jun 30, 2011 $10.29M
Cost Of Revenue restated Q2 2012 · Jun 30, 2011 $16.38M
Revenue Q2 2012 · Jun 30, 2012 $14.03M
Revenue Q2 2012 · Jun 30, 2012 $26.22M
Revenue Q2 2012 · Jun 30, 2011 $11.63M
Revenue restated Q2 2012 · Jun 30, 2011 $19.02M